Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Axes 15 Percent of its Workforce

NEW YORK, March 17 (GenomeWeb News) - Lynx Therapeutics has cut 15 percent of its workforce, the Hayward, Calif.-based company said today.


The layoffs leave the company with 76 employees.


Lynx is commercializing its Massively Parallel Signature Sequencing analysis platform.


Kevin Corcoran, the company's chief executive officer, said Lynx plans to expand new applications for its DNA sequencing services, and continue to develop its gene-expression services.


"We believe we are well-positioned to execute on our strategy, while keeping costs under control," he said in a statement. "We appreciate the contributions made by former employees and offer them our sincere thanks."


The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.